Insiders Anagenics Limited

Equities

Market Closed - Australian S.E. Other stock markets 02:10:57 2024-05-27 am EDT			5-day change	1st Jan Change
0.009 ^AUD	0.00%		+28.57%	-52.63%

May. 24	Anagenics Signs Midkine Antibody Licencing Deal with Roquefort Therapeutics	MT
Mar. 08	Anagenics Appoints CEO	MT

Anagenics Appoints CEO	Mar. 07	MT
Anagenics Limited Announces Board Executive Changes	23-10-01	CI
Anagenics Appoints CEO/Managing Director	23-03-28	MT
Anagenics Limited Appoints Scott Greasley as Managing Director, Effective from 1 April 2023	23-03-28	CI
Anagenics Limited Announces CEO Changes	23-03-28	CI
Anagenics Limited Appoints Karen Matthews as Non-Executive Director	23-02-13	CI
Anagenics Approves the Election of Mr. Alexander Beard as A Director	22-11-28	CI
Anagenics Limited Announces Resignation of Dennis Eck as Director	22-10-16	CI
Anagenics Limited Appoints Scott Mitchell Greasley as Director	22-07-07	CI
Anagenics Promotes Financial Controller to Acting CEO	22-02-28	MT
Anagenics Limited Appoints Matthew Dudek as Acting Chief Executive Officer, Effective 28 February 2022	22-02-28	CI
Anagenics Limited Appoints Mr. Alexander Beard as Director	22-02-14	CI
Anagenics Limited Announces Management Changes	22-02-14	CI
Anagenics Limited Announces Management Changes	22-02-14	CI
Cellmid Limited has Changed its Name to Anagenics Limited	21-12-15	CI
Cellmid Limited Appoints Phillip Christopher as Non-Executive Director, Effective 5 November 2021	21-11-01	CI
Cellmid Limited Announces Executive Changes	20-12-23	CI
Cellmid Limited Appoints Sarah Eck-Thompson as Director	20-12-02	CI
Cellmid Limited Announces Management Changes	20-10-20	CI
Cellmid Limited Appoints Dr. Dominic Burg as Chief Operating Officer Effective 1 July 2020	20-05-31	CI

No results for this search